Materson BJ, Reda DJ, Cushman WC. Single-drug therapy for hypertension in men. N Engl J Med 1993; 328: 914–921.
Webster J, Koch HF. Aspects of tolerability of centrally acting antihypertensive drugs. J Cardiovasc Pharm 1996; 27: 49–54.
Reis DJ, Regunathan S, Meeley MP. Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion. Am J Hypertens 1992; 5: 51S–57S.
Culebras X, Van Gessel E, Hoffmeyer P, Gamulin Z. Clonidine combined with long acting anesthetic does not prolong postoperative analgesia after brachial plexus blocks but does induce hemodynamic changes. Anesth Analg 2001; 92: 199–204.
El Saied AH, Steyn MP, Ansermino JM. Clonidine prolongs the effect of ropivacaine for axillary brachial plexus blockade. Can J Anaesth 2000; 47: 962–967.
Akhondzadeh S, Ahmadi-Abhari SA, Assadi SM, Shabestari OL, Kashani AR, Farzanehgan ZM. Double-blind randomized controlled trial of baclofen versus clonidine in the treatment of opiates withdrawal. J Clin Pharm Ther 2000; 25: 347–353.
Berggren U, Fahlke C, Norrby A, Zachrisson O, Balldin J. Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence. Drug Alcohol Depend 2000; 57: 255–260.
Falhke C, Berggren U, Balldin J. Cardiovascular responces to clonidine in alcohol withdrawal: are they related to psychopathology and mental well-being? Alcohol 2000; 21: 231–237.
Holsapple MP, Malave A, Lowry MT, Kim GKW. Central and peripheral antiinflammatory actions by clonidine and structurally related imidazoline analog. J Pharmacol Exp Ther 1984; 229: 399–403.
Holsapple MP, Trizzino J, Nichols DE, Kim GKW. Therapeutic and adjuvantive applications of an imidazoline antiinflammatory agent. J Pharmacol Exp Ther 1983; 224: 567–571.
Kulkarni SK, Mehta AK, Kunchandry J. Antiinflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw edema in rats. Arch Int Pharmacodyn Ther 1986; 279: 324–334.
Heller A, Koch T, Schmeck J, van Ackern K. Lipid mediators in inflammatory disorders. Drugs 1998; 55: 487–496.
Chang J, Blazek E, Skowronek M, Marinari L, Carlson RP. The antiinflammatory action of guanabenz is mediated through 5-lipogenase and cyclooxygenase inhibition. Eur J Pharmacol 1987; 142: 197–205.
Robert B, Petit JY, Grimanud N, Juge M, Welin L. Effects of clonidine on experimental brain edema in the rat. Agents Actions 1992; 37: 268–272.
Petroianu G, Helfrich U, Schmitt A, Bergler W, Rufer R. Dose-dependent inhibition of phospholipase A2 by paraoxon in vitro: prelimary results. J Appl Toxicol 1997; 17: 421–424.
Flesch I, Schmidt B, Ferber E. Acyl chain specificity and kinetic properties of phospholipase A1 and A2 of bone marrow derived macrophages. Z Naturforsch 1985; 40c: 356–363.
Sundaram GS, Shakir KMM, Barnes G, Margolis S. Release of phospholipase A2, and triglyceride lipase from rat liver. Biol Chem 1978; 253: 7703–7710.
MacPherson RD. The pharmacological basis of contemporary pain mangement. Pharmacol Ther 2000; 88: 163–185.
Dahl V, Raeder JC. Non-opioid postoperative analgesia. Acta Anaesthesiol Scand 2000; 44: 1191–1203.
Tejwani GA, Rattan AK. Antagonism of antinociception produced by intrathecal clonidine by ketorolac in the rat: the role of the opioid system. Anesth Analg 2000; 90: 1152–1156.
Mendez R, Eisenach JC, Kashtan K. Epidural clonidine analgesia after caesarean section. Anesthesiology 1990; 73: 848–852.
Filos KS, Goudas LC, Patroni O, Polyzou V. Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose-response study. Anesthesiology 1994; 81: 591–601.
Piper SN, Suttner SW, Schmidt CC, Maleck WH, Kumle B, Boldt J. Nefopam and clonidine in the prevention of postanaesthetic shivering. Anaesthesia 1999; 54: 683–702.
Piper SN, Röhm KD, Suttner SW, Maleck WH, Kranke P, Boldt J. A comparison of nefopam and clonidine for the prevention of postanaesthetic shivering: a comparative, double-blind and placebo-controlled dose-ranging study. Anaesthesia 2004; 59: 559–564.
Lowenthal DT, Matzek KM, MacGregor TR. Clinical pharmakokinetics of clonidine. Clin Pharmacokinet 1988; 14: 287–310.
Zielmann S, Petrow H, Walther P, Henze T. Intensive care delirium syndromes. Anaesthesiol Reanim 2003; 28: 8–12.
Pruzanski W, Vadas P, Stefanski E, Urowitz MB. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. Rheumatol 1985; 12: 211–216.
Pruzanski W, Vadas P, Browning J. Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. J Lipid Mediat 1993; 8: 161–167.
Vadas P, Pruzanski W, Farewell V. A predictive model for the clearance of soluble phospholipase A2 during septic shock. J Clin Lab Med 1991; 118: 471–475.
Taube C, Hauser A, Dunemann A, Forster W. Changes in prostaglandin synthesis in aorta, brain, kidney medulla of normal rats treated with antihypertensive drugs. Acta Biol Med Ger 1978; 37: 889–890.